Intelligence; Optimised Podcast

Australia produces some of the cleanest, highest-quality food on the planet. But less than two percent of global venture capital flows into agriculture and food technology, a sector that represents roughly twelve to thirteen percent of Australian GDP. That gap is not a minor inefficiency. It is a structural vulnerability.

In Part 2 of this conversation, Todd Crowley continues with Mark Gustowski and Timothy Hui from Mandalay Venture Partners to examine exactly where that capital needs to go and what happens when it doesn't arrive in time.

The discussion opens on Harvest Bee, a plant protein company that has solved two problems most alternative protein players haven't: texture and label cleanliness. With around a dozen ingredients and a dehydrated format that needs no cold chain, Harvest Bee is positioned for markets where infrastructure is the limiting factor, including Indonesia's presidential school feeding programme, which aims to put one meal a day in front of every child across an archipelago with serious logistics constraints.

From there the conversation moves to Health Food Symmetry, a functional fibre company targeting the gap left by inulin in the baking and cereals industry. Mark and Tim frame fibre as the next macro-nutrient investment wave after protein — and the internal tension at Mandalay is less about whether to back it than when the broader market will arrive.

That timing question is the spine of the episode. Agri-food VC exits cluster in the $200 million to $600 million range. The category consistently delivers top-quartile returns when managed with domain expertise. But internal rate of return is a function of time, not just outcome and getting the commercialisation cycle, company readiness, and acquirer appetite to align simultaneously is where the real work happens.

The episode closes with a flag on Global AgInvest Australia in Brisbane, June 10 to 11 - the first time the event has left New York and Tokyo - a signal of where the region is heading.

For deeper briefs on agri-food capability and Indo-Pacific food security, find the analysis inside Vaxa Bureau.

Australian food is 13 per cent of GDP. It gets less than 2 per cent of venture capital. That gap is not an accident. It is where the entire conversation starts.

Todd Crowley sits down with Mark Gustowski and Tim Hui of Mandalay Venture Partners to work through why institutional money has stayed out of Australian agrifood for so long, and what the cautious capital is missing.

Part 1 covers:
The petroleum-derived blue colour sitting in your kids' confectionery and sports drinks. The US is moving to ban it. It is still on shelves here.

FUL Foods, the spirulina-derived natural blue already replacing it, and why a fix this obvious took this long to fund.

The 2 per cent of capital / 13 per cent of GDP problem, and why allocators trained on tech keep misreading food.

Why Beyond Meat made every investor in this category wrong about the lesson.

This is the structural read on why Australian agrifood has the demand, the science base and the runway, and still cannot get the cheque.

Part 2 covers the bets that prove the thesis. Watch it next.

What happens when the officer commanding Australia's forward-deployed surgical unit runs the same mission on her own time - faster, leaner, and without a joint logistics unit behind her?

Wing Commander Dr Ajitha Sugnanam commands 1 Expeditionary Health Squadron, the RAAF unit responsible for delivering surgical capability in austere operational environments. She also founded the Esesson Foundation, which has deployed clinical teams across 14 countries using a supply chain built from Toll freight partnerships, in-country pharmacies, government-coordinated visas, accommodation and flights, and volunteer clinicians giving up their weekends.

The comparison is instructive and uncomfortable. The ADF model is self-contained by design - own aircraft, loadmasters, pharmaceutical pipelines, joint logistics support. Essosson achieves comparable clinical outcomes at a fraction of the cost by building trust-based collaborative supply chains and training local capacity rather than replacing it.

This episode forces three questions every defence capability planner should sit with:
- If your forward surgical capability depends on a self-contained logistics chain, what happens when that chain is contested or unavailable?

- The same clinician shortage constraining civilian health in PNG will constrain your coalition surgical capacity. Are those risks being assessed together or in separate columns?

- When a CO can do it lighter and faster outside the wire, what does that tell you about how defence capability is being designed, funded, and measured?

Dr Sugnanam is direct about the gap between military mindset and civilian adaptability in field operations — and about what resource-constrained deployments teach practitioners that no garrison environment can. The operational lessons here apply directly to how Australia plans, equips, and sustains forward health capability across the Indo-Pacific.

If your portfolio touches force health readiness, ADF expeditionary capability, or defence logistics, this conversation will sharpen how you read the next capability review.

Find deeper analysis and briefs inside Vaxa Bureau.

Australia feeds the region, but the mineral that makes that possible is almost entirely imported, processed offshore, and held in supply chains that break on a predictable cycle.

In this episode of Intelligence Optimised, Todd Crowley sits down with John Cotter, founder of Northwest Phosphate and the man sitting on the largest phosphate deposit in Australia, 130km northwest of Mount Isa. The conversation was recorded before the current global fertiliser crisis. Listen to how accurate the warning was. Then ask yourself why nobody moved on it.

Phosphate is the kickoff nutrient for photosynthesis and root development. Without it, crop yields collapse quickly. Australia has no strategic fertiliser reserve - none. Phosphate Hill mine at Mount Isa has shut. The single super plant in Geelong is gone. Wesfarmers CSP in Perth is closed. We are down to one domestic phosphate rock miner.

That miner is Northwest Phosphate. Their Paradise South deposit holds 201 million tonnes of measured reserve in Stage 1, with a total resource close to 800 million tonnes at 34.5–35% P2O5 - above the global benchmark. The path to market runs through repurposed Century Mine infrastructure: a $2 billion-plus flotation plant and a 304km slurry line to the Port of Karumba, keeping 400 jobs in one of Australia's most remote regions for another 50 to 100 years.

The strategic picture goes further than food. Downstream processing of this phosphate rock produces high-grade phosphoric acid, a direct feedstock for lithium iron phosphate (LFP) batteries. The calcium gypsum by-product carries light and heavy rare earths used in military platform manufacturing. One resource. Four sovereign capability threads: food, fertiliser, batteries, defence materials.

John also maps what happens in the first 24 hours of a supply chain cutoff, which plants get nationalised, which inputs disappear, and why Australia's position is structurally identical to its AdBlue exposure and its single remaining vaccine batch facility.

This is the episode for food security planners, critical minerals program owners, and anyone whose portfolio depends on assumptions that have never been stress-tested.

Find deeper briefs inside Vaxa Bureau.

Australia commissioned more grid-scale battery storage in 2025 than the previous eight years combined. Most of those systems have no cell-level visibility, no long-term support plan, and no answer to what happens when the supply chain that feeds them gets cut.

In Part 2, Todd Crowley and Dominic Spooner move from diagnosis to decisions. What sovereign battery manufacturing actually requires. Why defence and infrastructure planners are still catching up while sodium-ion is already commercially available. Why batteries rarely fail because of chemistry — and what they actually fail because of. And the three questions every procurement officer should answer before the decision gets made for them.

What is your actual exposure. Why it matters to your specific operation. What you do before the disruption forces the answer.

Find deeper analysis inside Vaxa Bureau.